ROSEN, NATIONAL TRIAL COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – NMRAon February 16, 2025 at 3:12 am
1 year ago
Post Content Post Content
ROSEN, LEADING INVESTOR COUNSEL, Encourages FMC Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – FMCon February 17, 2025 at 11:24 pm Date February 18, 2025 In relation to Markets News ROSEN, SKILLED INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRKon February 16, 2025 at 2:28 am Date February 16, 2025 In relation to Markets News ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – GSKon February 16, 2025 at 2:24 am Date February 16, 2025 In relation to Markets News
